AAAAAA

   
Results: 1-16 |
Results: 16

Authors: Guiso, G Caccia, S
Citation: G. Guiso et S. Caccia, Distribution of the methylpiperazinopyridobenzoxazepine derivative JL13, apotential antipsychotic, in rat brain, J PHARM PHA, 53(3), 2001, pp. 317-321

Authors: Campiani, G Aiello, F Fabbrini, M Morelli, E Ramunno, A Armaroli, S Nacci, V Garofalo, A Greco, G Novellino, E Maga, G Spadari, S Bergamini, A Ventura, L Bongiovanni, B Capozzi, M Bolacchi, F Marini, S Coletta, M Guiso, G Caccia, S
Citation: G. Campiani et al., Quinoxalinylethylpyridylthioureas (QXPTs) as potent non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors. Further SAR studies and identification of a novel orally bioavailable hydrazine-based antiviral agent, J MED CHEM, 44(3), 2001, pp. 305-315

Authors: Maga, G Ramunno, A Nacci, V Locatelli, GA Spadari, S Fiorini, I Baldanti, F Paolucci, S Zavattoni, M Bergamini, A Galletti, B Muck, S Hubscher, U Giorgi, G Guiso, G Caccia, S Campiani, G
Citation: G. Maga et al., The stereoselective targeting of a specific enzyme-substrate complex is the molecular mechanism for the synergic inhibition of HIV-1 reverse transcriptase by (R)-(-)-PPO464 - A novel generation of nonnucleoside inhibitors, J BIOL CHEM, 276(48), 2001, pp. 44653-44662

Authors: Invernizzi, RW Parini, S Sacchetti, G Fracasso, C Caccia, S Annoni, K Samanin, R
Citation: Rw. Invernizzi et al., Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortex, BR J PHARM, 132(1), 2001, pp. 183-188

Authors: Campiani, G Fabbrini, M Morelli, E Nacci, V Greco, G Novellino, E Maga, G Spadari, S Bergamini, A Faggioli, E Uccella, I Bolacchi, F Marini, S Coletta, M Fracasso, C Caccia, S
Citation: G. Campiani et al., Non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis and biological evaluation of novel quinoxalinylethylpyridylthioureas as potent antiviral agents, ANTIVIR CHE, 11(2), 2000, pp. 141-155

Authors: Caccia, S
Citation: S. Caccia, Biotransformation of post-clozapine antipsychotics - Pharmacological implications, CLIN PHARMA, 38(5), 2000, pp. 393-414

Authors: Lucas, G De Deurwaerdere, P Caccia, S Spampinato, U
Citation: G. Lucas et al., The effect of serotonergic agents on haloperidol-induced striatal dopaminerelease in vivo: opposite role of 5-HT2A and 5-HT2C receptor subtypes and significance of the haloperidol dose used, NEUROPHARM, 39(6), 2000, pp. 1053-1063

Authors: Fracasso, C Ceci, A Vanoni, P Caccia, S
Citation: C. Fracasso et al., A high-performance liquid chromatographic assay for 5-methoxy-3-[N-(4-(4-fluoro-phenyl)-4-oxobutyl)-1,2,5,6-tetrahydropyridin-3-yl-methyl]-1H-indole (BIMG 80), a potential antipsychotic agent, and its application in brain-to-plasma distribution studies in the rat, J LIQ CHR R, 22(11), 1999, pp. 1785-1795

Authors: Cossu, ML Caccia, S Coppola, M Fais, E Ruggiu, M Fracasso, C Nacca, A Noya, G
Citation: Ml. Cossu et al., Orally administered ranitidine plasma concentrations before and after biliopancreatic diversion in morbidly obese patients, OBES SURG, 9(1), 1999, pp. 36-39

Authors: Caccia, S Denisov, I Perrella, M
Citation: S. Caccia et al., The kinetics of the reaction between NO and O-2 as studied by a novel approach, BIOPHYS CH, 76(1), 1999, pp. 63-72

Authors: Gobbi, M Dalla Valle, F Ciapparelli, C Diomede, L Morazzoni, P Verotta, L Caccia, S Cervo, L Mennini, T
Citation: M. Gobbi et al., Hypericum perforatum L. extract does not inhibit 5-HT transporter in rat brain cortex, N-S ARCH PH, 360(3), 1999, pp. 262-269

Authors: Guinto, ER Caccia, S Rose, T Futterer, K Waksman, G Di Cera, E
Citation: Er. Guinto et al., Unexpected crucial role of residue 225 in serine proteases, P NAS US, 96(5), 1999, pp. 1852-1857

Authors: Campiani, G Morelli, E Gemma, S Nacci, V Butini, S Hamon, M Novellino, E Greco, G Cagnotto, A Goegan, M Cervo, L Dalla Valle, F Fracasso, C Caccia, S Mennini, T
Citation: G. Campiani et al., Pyrroloquinoxaline derivatives as high-affinity and selective 5-HT3 receptor agonists: Synthesis, further structure-activity relationships, and biological studies, J MED CHEM, 42(21), 1999, pp. 4362-4379

Authors: Campiani, G Morelli, E Fabbrini, M Nacci, V Greco, G Novellino, E Ramunno, A Maga, G Spadari, S Caliendo, G Bergamini, A Faggioli, E Uccella, I Bolacchi, F Marini, S Coletta, M Nacca, A Caccia, S
Citation: G. Campiani et al., Pyrrolobenzoxazepinone derivatives as non-nucleoside HIV-1 RT inhibitors: Further structure-activity relationship studies and identification of more potent broad-spectrum HIV-1 RT inhibitors with antiviral activity, J MED CHEM, 42(21), 1999, pp. 4462-4470

Authors: Caccia, S Grossi, G Fracasso, C Nacca, A Cagnotto, A Mennini, T Ghia, M Roma, G
Citation: S. Caccia et al., Acid-catalysed hydrolysis and benzodiazepine-like properties of 5-(dialkylamino)- and 5-(alkylthio)-substituted 8-chloro-6-phenyl-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepines in mice, J PHARM PHA, 50(7), 1998, pp. 723-728

Authors: Nacca, A Guiso, G Fracasso, C Cervo, L Caccia, S
Citation: A. Nacca et al., Brain-to-blood partition and in vivo inhibition of 5-hydroxytryptamine reuptake and quipazine-mediated behaviour of nefazodone and its main active metabolites in rodents, BR J PHARM, 125(7), 1998, pp. 1617-1623
Risultati: 1-16 |